Expertise in
9
conditions
Expertise in
9
conditions
1540 E Hospital Dr, Floor 7 Reception C, 
Ann Arbor, MI 

Overview

Dr. Gregory Yanik has been a faculty member within the Blood and Marrow Transplant Program and Division at the University of Michigan since 1992. He was born and raised in the Detroit area, attended medical school at Wayne State University and trained in hematology-oncology at Cincinnati Children’s Hospital. He and his wife Marybeth have three grown children. Dr. Yanik has been the recipient of many prestigious awards in recognition of his contributions to medical research, clinical care, and education, including the Leland and Elaine Blatt Professorship of Pediatric Oncology, the University of Michigan Pediatric Teacher of the Year Award, and the Leukemia and Lymphoma Society Chairman’s Citation for Outstanding Service. Dr. Yanik is the founder of and chairs the Executive Committee for the Children’s Hematology Alliance of Michigan (CHAMI), a unique alliance of pediatric hematology/practice teams in the State of Michigan whose goal is to continuously improve the quality of care for children with these medical conditions regardless of where they are treated in the State. In addition to these many activities, Dr. Yanik makes time to serve on the Executive Committee for Make a Wish Michigan.

Dr. Yanik is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Graft Versus Host Disease (GvHD), Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 127 peer reviewed articles and participating in 4 clinical trials.

Graduate Institution

Wayne State University, 1983

Residency

William Beaumont Hospital, Internal Medicine and Pediatrics, 1987

Specialties

Pediatrics
Internal Medicine

Licenses

Internal Medicine in MI

Fellowships

Children's Hospital Medical Center, Pediatric Hematology/Oncology, 1991
Children Hospital Medical Center, Pediatric Hematology/Oncology, 1991

Hospital Affiliations

University Of Michigan Health System

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

C. S. Mott Children's Hospital
1540 E Hospital Dr, Floor 7 Reception C, Ann Arbor, MI 48109
Other Locations
Pulmonary Clinic
1500 E Medical Center Dr, Floor 3 Reception C, Ann Arbor, MI 48109

Additional Areas of Focus

Dr. Yanik has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

Managed Access Programs for CTL019, Tisagenlecleucel
A Phase I Study of Lenalidomide and Anti-GD2 Mab Ch14.18 +/- Isotretinoin in Patients With Refractory/Recurrent Neuroblastoma
View 3 Less Clinical Trials
Similar Doctors
Expertise in
31
conditions
Expertise in
31
conditions
Referral may be required

C. S. Mott Children's Hospital

1540 E Hospital Dr, Floor 7 Reception C, 
Ann Arbor, MI 
 (0.2 miles away)
Languages Spoken:
English
Offers Telehealth

Kelly Walkovich is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Walkovich is highly rated in 31 conditions, according to our data. Her clinical expertise encompasses Hemophagocytic Lymphohistiocytosis, Infantile Neutropenia, Non-Langerhans-Cell Histiocytosis, Histiocytosis, and Bone Marrow Transplant.

Expertise in
1
conditions
Medical Genetics | Pediatrics
Expertise in
1
conditions
Medical Genetics | Pediatrics
Referral may be required

C. S. Mott Children's Hospital

1540 E Hospital Dr, Floor 6 Reception C, 
Ann Arbor, MI 
 (0.2 miles away)
Languages Spoken:
English

Donna Martin is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Martin is highly rated in 1 condition, according to our data. Her clinical expertise encompasses CHARGE Syndrome and Neurofibromatosis Type 1 (NF1).

Expertise in
5
conditions
Expertise in
5
conditions
Referral may be required

C. S. Mott Children's Hospital

1540 E Hospital Dr, Floor 7 Reception C, 
Ann Arbor, MI 
 (0.2 miles away)
Languages Spoken:
English

Dr. Steven Pipe is a Professor and the Laurence A. Boxer Research Professor of Pediatrics and Professor of Pathology at the University of Michigan, Ann Arbor, Michigan, USA. He is the medical director of the Pediatric Hemophilia and Coagulation Disorders Program and medical director of the Special Coagulation Laboratory. His clinical interests include bleeding and thrombotic disorders and congenital vascular anomalies. Dr Pipe also directs a basic research lab investigating coagulation factor VIII and the molecular mechanisms of hemophilia A. He has been actively involved in clinical trials with novel therapeutics for hemophilia including gene therapy. He was the 2015 recipient of the Leadership in Research Award from the National Hemophilia Foundation. He has served on the Board of Directors for the Hemostasis and Thrombosis Research Society, as Chair of the Board of Directors for the American Thrombosis and Hemostasis Network and currently as Chair of the Medical and Scientific Advisory Committee to the National Hemophilia Foundation. Dr. Pipe is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Hemophilia A, Hemophilia B, Blood Clots, and Von Willebrand Disease (VWD).

Frequently Asked Questions about Dr. Gregory A. Yanik

How do I make an appointment with Dr. Gregory A. Yanik?

You can book an appointment with Dr. Gregory A. Yanik by calling their office at 734-647-8902. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Gregory A. Yanik a top-rated expert for Neuroblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gregory A. Yanik is classified as an Elite expert for Neuroblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Gregory A. Yanik specialize in?

While Dr. Gregory A. Yanik is a Pediatrics, they have specific expertise in Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, and Graft Versus Host Disease (GvHD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.

Does Dr. Gregory A. Yanik participate in research or clinical trials?

Yes. Dr. Gregory A. Yanik has published 127 articles and abstracts on conditions like Neuroblastoma. You can view a list of Dr. Gregory A. Yanik's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Gregory A. Yanik accept my insurance?

Dr. Gregory A. Yanik accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 734-647-8902 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Yanik's expertise for a condition
ConditionClose
View All 14 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile